The authors used an engineered hematopoietic stem cell–based platform that delivers cytokines to the tumor microenvironment to improve the efficacy of B7-homolog 3–targeting CAR T cells in an orthotopic syngeneic mouse model of glioblastoma.
[Science Translational Medicine]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News